Literature DB >> 1963624

Fatal primary Epstein-Barr virus infection masquerading as histiocytic medullary reticulosis in young children in Taiwan.

I J Su1, D T Lin, H C Hsieh, S H Lee, J Chen, R L Chen, C Y Lee, J Y Chen.   

Abstract

We reported 3 fatal cases of primary Epstein-Barr virus (EBV) infection resembling histiocytic medullary reticulosis (HMR) in young children in Taiwan, where an HMR-like illness has been previously found to be prevalent. The disease ran a fulminant course, manifesting as fever, anemia, jaundice, skin rash, pulmonary infiltration, and/or hepatosplenomegaly lasting for only 1-3 weeks. Laboratory tests revealed no hemolytic anemia and Coombs test was negative. Sepsis or HMR was the main clinical differential. At autopsy, the spleen, liver, lymph node, lung, and bone marrow showed infiltration of atypical "histiocytes" or blasts, lymphocytes, and mature histiocytes with hemophagocytosis. Immunophenotype and gene rearrangement studies of the lymphoid tissues revealed that these atypical "histiocytes" were actually polyclonal B immunoblasts in one case and transformed T lymphocytes in the remaining 2 cases, representing two different types of virus-host interaction. Southern blot and in situ hybridization studies on frozen lymphoid tissues demonstrated the presence of EBV DNA in all 3 patients; the study for cytomegalovirus was negative. The young age of these patients, closely correlated with the prevalent age of primary EBV infection in the general populations in Taiwan, strongly suggest that these childhood cases of previously diagnosed HMR-like disease may actually represent a lethal form of primary EBV infection or fatal infectious mononucleosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963624

Source DB:  PubMed          Journal:  Hematol Pathol        ISSN: 0886-0238


  6 in total

1.  Atypical clonal T-cell proliferation in infectious mononucleosis.

Authors:  U R Malik; L Oleksowicz; J P Dutcher; H Ratech; M J Borowitz; P H Wiernik
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

2.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

3.  Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.

Authors:  Ren-Ching Wang; Sheng-Tsung Chang; Yen-Chuan Hsieh; Wan-Ting Huang; Jeng-Dong Hsu; Chih-En Tseng; Ming-Chung Wang; Wei-Shou Hwang; John Wang; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 4.  Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Authors:  Qingqing Cai; Kailin Chen; Ken H Young
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

5.  [Clinical analysis of 13 patients with EB virus-positive T-cell lymphoproliferative disorders in adults].

Authors:  P F Shi; Y P Xie; Y Xu; S X Qian; K Chen; D Q Gao; X L Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-03-14

6.  Severe chronic active EBV infection in an adult patient: case report.

Authors:  Sang-Yoon Ha; Chul-Won Chung; Young H Ko
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.